On June 25, 2025, the Centers for Medicare & Medicaid Services (CMS) will convene a panel of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC). The MEDCAC panel will examine what clinical endpoints should be of interest to CMS in studies of devices for management of tremor in patients with Parkinson’s Disease or essential tremor. By voting on specific questions, and through discussion, MEDCAC panel members will advise CMS about the ideal clinical endpoints to measure in research studies on this topic, as well as appropriate measurement instruments, definitions of minimal clinically important differences and adequate follow-up duration.
To learn more about the MEDCAC meeting and how to participate, please see the MEDCAC Meeting page at: https://www.cms.gov/medicare-coverage-database/view/medcac-meeting.aspx?medcacid=82&year=all&sortBy=meetingdate&bc=15
|